Further, a pull-down assay of lysates from BCP-1 cells, a KSHV-infected B-cell lymphoma cell line, with an anti-BRD2 antibody results in the immunoprecipitation of both BRD2 and LANA, indicating interaction between BRD2 and LANA in vivo [112]. The gene discussed is BRD2; the disease is B-cell non-Hodgkin lymphoma.